Mature data collected from North America as well as in Europe demonstrates how research volunteers will travel large distances to screen or enroll contemporaneously in multiple clinical trials as duplicate subjects in clinical trials. The numbers are significant and occur across both early and later phase studies. Why risk these safety and data quality issues? VCT is an easy to implement global research subject database that is cost effective GDPR and HIPAA compliant system used by countless sites, CROs, and Pharma companies.
https://lnkd.in/etwhixy (Verified Clinical Trials) detects and prevents duplicate subjects or professional research subjects from entering your clinical trial. Duplicate subjects in CNS clinical trials and phase 1 clinical trials have some of the highest numbers, but duplicate subjects are seen across all phases of research and most therapeutic areas too.
